Literature DB >> 19155808

Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis.

Inge van Rossum1, Maarten Boomsma, Diederik Tenback, Catherine Reed, Jim van Os.   

Abstract

Research suggests that cannabis use affects negatively on onset and outcome of schizophrenia, but less is known about possible effects in mood disorders. Bipolar in- and outpatients (N = 3459) were enrolled in an observational study. The influence of cannabis exposure on clinical and social treatment outcome measures was examined over the course of 1 year, as well as the effects on these associations of third mediating variables. Over 12 months of treatment, cannabis users exhibited less compliance and higher levels of overall illness severity, mania, and psychosis compared with nonusers. Additionally, cannabis users experienced less satisfaction with life and had a lower probability of having a relationship compared with nonusers. There was little evidence that cannabis-outcome associations were mediated by third variables. An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155808     DOI: 10.1097/NMD.0b013e31819292a6

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  25 in total

Review 1.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

2.  Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Authors:  Abir T El-Alfy; Kelly Ivey; Keisha Robinson; Safwat Ahmed; Mohamed Radwan; Desmond Slade; Ikhlas Khan; Mahmoud ElSohly; Samir Ross
Journal:  Pharmacol Biochem Behav       Date:  2010-03-21       Impact factor: 3.533

3.  [Managing the use of cannabis in a young population in primary care].

Authors:  Agustín Madoz-Gúrpide; Enriqueta Ochoa Mangado
Journal:  Aten Primaria       Date:  2011-02-20       Impact factor: 1.137

4.  Cannabis involvement in individuals with bipolar disorder.

Authors:  Arpana Agrawal; John I Nurnberger; Michael T Lynskey
Journal:  Psychiatry Res       Date:  2010-07-31       Impact factor: 3.222

Review 5.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

6.  Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder.

Authors:  Raphael J Braga; Katherine E Burdick; Pamela Derosse; Anil K Malhotra
Journal:  Psychiatry Res       Date:  2012-07-18       Impact factor: 3.222

7.  The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study.

Authors:  Jihyung Hong; Catherine Reed; Diego Novick; Josep Maria Haro; Frank Windmeijer; Martin Knapp
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Susan J Wenze; Gary Epstein-Lubow; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2015-10-23       Impact factor: 3.735

9.  Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.

Authors:  Corneliu N Stanciu; Mary F Brunette; Nikhil Teja; Alan J Budney
Journal:  Psychiatr Serv       Date:  2021-02-03       Impact factor: 3.084

10.  Cannabis and Mood Disorders.

Authors:  Aliya M Lucatch; Alexandria S Coles; Kevin P Hill; Tony P George
Journal:  Curr Addict Rep       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.